Jove
Visualize
Contact Us

Related Experiment Videos

Treatment-resistant anxiety disorders.

A Bystritsky1

  • 1UCLA, Department of Psychiatry, Los Angeles, CA 90095-6968, USA. abystritsky@mednet.ucla.edu

Molecular Psychiatry
|July 19, 2006
PubMed
Summary

Anxiety disorders are common and disabling, with many patients not fully responding to standard treatments. This review explores reasons for treatment resistance and strategies to improve outcomes for those with chronic anxiety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcranial focused ultrasound for the treatment of tremor: A preliminary case series.

Brain stimulation·2023
Same author

Use of transcranial low-intensity focused ultrasound for targeted delivery of stem cell-derived exosomes to the brain.

Scientific reports·2023
Same author

An examination of the bidirectional relationship between functioning and symptom levels in patients with anxiety disorders in the CALM study.

Psychological medicine·2014
Same author

Trauma Exposure in Anxious Primary Care Patients.

Journal of psychopathology and behavioral assessment·2013
Same author

Symptom differences among anxiety patients in clinics with differing treatment orientations : a pilot investigation.

The Journal of psychotherapy practice and research·2012
Same author

Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness.

Journal of psychiatric research·2012
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Anxiety disorders are the most prevalent psychiatric conditions in the US, causing significant disability and reduced quality of life.
  • Standard treatments like SSRIs and CBT are effective for many, but approximately 40% of patients exhibit treatment resistance.
  • Treatment-resistant anxiety is associated with severe functional impairment and increased suicidal ideation.

Purpose of the Study:

  • To review the multifaceted reasons contributing to treatment resistance in anxiety disorders.
  • To explore current and emerging strategies for overcoming treatment resistance in chronic anxiety.

Main Methods:

  • Literature review of epidemiological studies on anxiety disorder prevalence and treatment outcomes.
  • Analysis of biological, treatment-specific, and social factors implicated in treatment resistance.
  • Synthesis of current therapeutic strategies and future directions for managing refractory anxiety.

Main Results:

  • Treatment resistance in anxiety disorders is influenced by a complex interplay of factors.
  • Biological underpinnings, specific treatment characteristics, and psychosocial elements all play a role.
  • Identifying these factors is crucial for developing targeted interventions.

Conclusions:

  • Understanding the drivers of treatment resistance is essential for improving patient care.
  • Novel therapeutic approaches are needed to address the needs of individuals with chronic and refractory anxiety.
  • Further research into personalized medicine and combination therapies holds promise for reducing treatment resistance.

Related Experiment Videos